Dominant negative Ras as an anticancer agent

被引：2
作者：
Guo, Wei [1 ]
Fang, Bingliang [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Unit 445, Houston, TX 77030 USA
来源：
CANCER BIOLOGY & THERAPY | 2006年 / 5卷 / 11期
关键词：
Ras; dominant negative; anticancer; CAAX; N116Y;
D O I：
10.4161/cbt.5.11.3681
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1492 / 1493
页数：2
相关论文
共 20 条
[1]   PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS [J].
BOS, JL ;
FEARON, ER ;
HAMILTON, SR ;
VERLAANDEVRIES, M ;
VANBOOM, JH ;
VANDEREB, AJ ;
VOGELSTEIN, B .
NATURE, 1987, 327 (6120) :293-297
[2]   Ras family signaling - Therapeutic targeting [J].
Cox, AD ;
Der, CJ .
CANCER BIOLOGY & THERAPY, 2002, 1 (06) :599-606
[3]  
Der C J, 1989, Cancer Treat Res, V47, P73
[4]   Distinct mechanisms determine the patterns of differential activation of H-Ras, N-Ras, K-Ras 4B, and M-Ras by receptors for growth factors or antigen [J].
Ehrhardt, A ;
David, MD ;
Ehrhardt, GRA ;
Schrader, JW .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (14) :6311-6323
[5]  
Hoa M, 2002, CANCER RES, V62, P7154
[6]   THE RAS SIGNAL-TRANSDUCTION PATHWAY [J].
KHOSRAVIFAR, R ;
DER, CJ .
CANCER AND METASTASIS REVIEWS, 1994, 13 (01) :67-89
[7]  
MILLS NE, 1995, CANCER RES, V55, P1444
[8]  
PELLEGATA NS, 1994, CANCER RES, V54, P1556
[9]  
Senmaru N, 1998, INT J CANCER, V78, P366, DOI 10.1002/(SICI)1097-0215(19981029)78:3<366::AID-IJC18>3.0.CO
[10]  
2-4
12